查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1679432

焦慮和憂鬱症治療市場規模、佔有率、趨勢分析報告：按藥物類型、適應症、分銷管道、地區和細分市場預測，2025 年至 2030 年

Anxiety Disorders And Depression Treatment Market Size, Share & Trends Analysis Report By Drug Type, By Indication (Depression, Anxiety), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

焦慮和憂鬱症治療市場的成長和趨勢

根據Grand View Research, Inc.的最新報告，全球焦慮和憂鬱症治療市場規模預計到2030年將達到192.8億美元，預計2025年至2030年期間的複合年成長率為3.8%。

全球憂鬱症盛行率的上升預計將在未來幾年推動市場成長。近年來，由於設備和心理療法的普及，對抗抗憂鬱症的需求有所下降。

易患憂鬱症的老年人數量不斷增加，以及恐懼症和整體焦慮症等焦慮症的增加，進一步導致了預測期內對抗抗憂鬱症治療精神疾病的需求不斷成長。此外，用於大腦刺激的醫療植入和使用基於智慧型手機應用程式的虛擬實境暴露療法等先進治療方法的引入為患者提供了創新的治療選擇。

焦慮和憂鬱症治療市場報告重點

  • 抗憂鬱症領域佔據市場主導地位，2024 年的收益佔有率最高，為 32.4%。
  • 焦慮症在 2024 年佔據市場主導地位，收益佔有率為 55.4%。這是由於成熟經濟體和發展中經濟體中恐懼症、社交焦慮症和其他類似疾病的增加。
  • 由於患者更喜歡附近且值得信賴的藥局，零售藥局領域將在 2024 年佔據最大的市場佔有率，達到 55.4%。
  • 北美焦慮和憂鬱症治療市場佔據全球市場主導地位，2024 年的收益佔有率為 37.6%。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章焦慮和憂鬱症治療市場變數、趨勢和範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 產業分析—波特五力分析
    • PESTLE分析
    • 管道分析

第4章焦慮與憂鬱症治療市場：按藥物類型進行的商業分析

  • 2024 年和 2030 年各藥物類型的市場佔有率
  • 藥品類型細分儀表板
  • 2018 年至 2030 年藥品市場規模、預測及趨勢分析
  • 抗憂鬱症
  • 抗焦慮藥物
  • 抗驚厥藥
  • 去甲腎上腺素促效劑
  • 非典型抗精神病藥物

5. 焦慮症與憂鬱症治療市場：適應症業務分析

  • 2024年及2030年的指示市場佔有率
  • 指示細分儀表板
  • 2018 年至 2030 年市場規模、預測與趨勢分析（按適應症）
  • 憂鬱症
  • 焦慮症

6. 焦慮與憂鬱症治療市場：通路業務分析

  • 2024年及2030年分銷通路市場佔有率
  • 分銷通路細分儀表板
  • 2018 年至 2030 年分銷通路市場規模、預測與趨勢分析
  • 醫院藥房
  • 零售藥局
  • 其他

第7章焦慮和憂鬱症治療市場：按地區估計和趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
    • 2018-2030年各國情況
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018-2030年各國情況
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 丹麥
    • 瑞典
  • 亞太地區
    • 2018-2030年各國情況
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 2018-2030年各國情況
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 2018-2030年各國情況
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章競爭格局

  • 參與者概述
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • Pfizer Inc.
    • H. Lundbeck A/S
    • GSK plc
    • Merck & Co., Inc.
    • Eli Lilly and Company
    • AstraZeneca
    • Bristol-Myers Squibb Company
    • Johnson & Johnson Services, Inc.
    • AbbVie Inc.
    • Sanofi
Product Code: GVR-1-68038-731-5

Anxiety Disorders And Depression Treatment Market Growth & Trends:

The global anxiety disorders and depression treatment market size is estimated to reach USD 19.28 billion by 2030, registering to grow at a CAGR of 3.8% from 2025 to 2030 according to a new report by Grand View Research, Inc. The rising incidence of depression worldwide is anticipated to drive the market growth in the coming years. Increasing adoption of devices and psychotherapies has resulted in the declining demand for antidepressants in recent years.

The rising geriatric population prone to depression and surging prevalence of anxiety disorders, including phobias and generalized anxiety disorder, are further contributing toward the growing demand for antidepressants to treat mental illnesses over the forecast period. Moreover, the introduction of technologically advanced therapies, such as medical implants used for brain stimulation and virtual reality exposure therapies using smartphone-based applications, furnish patients with innovative treatment alternatives.

Anxiety Disorders And Depression Treatment Market Report Highlights:

  • The antidepressants segment dominated the market and accounted for the highest revenue share of 32.4% in 2024.
  • Anxiety led the market with a revenue share of 55.4% in 2024, fueled by the increased presence of phobias, social anxiety disorders, and other similar conditions in both established and growing economies.
  • The retail pharmacies segment held the largest market share of 55.4% in 2024 due to patients' preference for nearby, trustworthy pharmacies.
  • North America anxiety disorders and depression treatment market dominated the global market with a revenue share of 37.6% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Drug Type
    • 1.2.2. Indication
    • 1.2.3. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Anxiety Disorders and Depression Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis

Chapter 4. Anxiety Disorders and Depression Treatment Market: Drug Type Business Analysis

  • 4.1. Drug Type Market Share, 2024 & 2030
  • 4.2. Drug Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Drug Type, 2018 to 2030 (USD Million)
  • 4.4. Antidepressants
    • 4.4.1. Antidepressants Market, 2018 - 2030 (USD Million)
  • 4.5. Anxiolytics
    • 4.5.1. Anxiolytics Market, 2018 - 2030 (USD Million)
  • 4.6. Anticonvulsants
    • 4.6.1. Anticonvulsants Market, 2018 - 2030 (USD Million)
  • 4.7. Noradrenergic Agents
    • 4.7.1. Noradrenergic Agents Market, 2018 - 2030 (USD Million)
  • 4.8. Atypical Antipsychotics
    • 4.8.1. Atypical Antipsychotics Market, 2018 - 2030 (USD Million)

Chapter 5. Anxiety Disorders and Depression Treatment Market: Indication Business Analysis

  • 5.1. Indication Market Share, 2024 & 2030
  • 5.2. Indication Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Indication, 2018 to 2030 (USD Million)
  • 5.4. Depression
    • 5.4.1. Depression Market, 2018 - 2030 (USD Million)
  • 5.5. Anxiety
    • 5.5.1. Anxiety Market, 2018 - 2030 (USD Million)

Chapter 6. Anxiety Disorders and Depression Treatment Market: Distribution Channel Business Analysis

  • 6.1. Distribution Channel Market Share, 2024 & 2030
  • 6.2. Distribution Channel Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 6.4. Hospital Pharmacies
    • 6.4.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
  • 6.5. Retail Pharmacies
    • 6.5.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Anxiety Disorders and Depression Treatment Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Norway Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Denmark Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Sweden
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Sweden Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Pfizer Inc.
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. H. Lundbeck A/S
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. GSK plc
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Merck & Co., Inc.
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Eli Lilly and Company
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. AstraZeneca
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Bristol-Myers Squibb Company
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Johnson & Johnson Services, Inc.
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. AbbVie Inc.
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Sanofi
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global anxiety disorders and depression treatment market, by region, 2018 - 2030 (USD Million)
  • Table 4. Global anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 5. Global anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 6. Global anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 7. North America anxiety disorders and depression treatment market, by country, 2018 - 2030 (USD Million)
  • Table 8. North America anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 9. North America anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 10. North America anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 11. U.S. anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 12. U.S. anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 13. U.S. Anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 14. Canada anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 15. Canada anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 16. Canada anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 17. Mexico anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 18. Mexico anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 19. Mexico anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 20. Europe anxiety disorders and depression treatment market, by country, 2018 - 2030 (USD Million)
  • Table 21. Europe anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 22. Europe anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 23. Europe anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 24. UK anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 25. UK anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 26. UK Anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 27. Germany anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 28. Germany anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 29. Germany anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 30. France anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 31. France anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 32. France Anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 33. Italy anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 34. Italy anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 35. Italy anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 36. Spain anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 37. Spain anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 38. Spain anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 39. Norway anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 40. Norway anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 41. Norway Anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 42. Denmark anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 43. Denmark anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 44. Denmark anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 45. Sweden anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 46. Sweden anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 47. Sweden anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 48. Asia Pacific anxiety disorders and depression treatment market, by country, 2018 - 2030 (USD Million)
  • Table 49. Asia Pacific anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 50. Asia Pacific anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 51. Asia Pacific anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 52. Japan anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 53. Japan anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 54. Japan anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 55. China anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 56. China anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 57. China anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 58. India anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 59. India anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 60. India anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 61. Australia anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 62. Australia anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 63. Australia anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 64. South Korea anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 65. South Korea anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 66. South Korea anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 67. Thailand anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 68. Thailand anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 69. Thailand anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 70. Latin America anxiety disorders and depression treatment market, by country, 2018 - 2030 (USD Million)
  • Table 71. Latin America anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 72. Latin America anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 73. Latin America anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 74. Brazil anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 75. Brazil anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 76. Brazil anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 77. Argentina anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 78. Argentina anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 79. Argentina anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 80. Middle East & Africa Anxiety disorders and depression treatment market, by country, 2018 - 2030 (USD Million)
  • Table 81. Middle East & Africa anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 82. Middle East & Africa anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 83. Middle East & Africa anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 84. South Africa anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 85. South Africa anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 86. South Africa anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 87. Saudi Arabia anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 88. Saudi Arabia anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 89. Saudi Arabia anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 90. UAE anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 91. UAE anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 92. UAE anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 93. Kuwait anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 94. Kuwait anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 95. Kuwait anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Anxiety disorders and depression treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Drug type and indication outlook (USD Million)
  • Fig. 10 Distribution channel outlook (USD Million)
  • Fig. 11 Competitive landscape
  • Fig. 12 Anxiety disorders and depression treatment market dynamics
  • Fig. 13 Anxiety disorders and depression treatment market: Porter's five forces analysis
  • Fig. 14 Anxiety disorders and depression treatment market: PESTLE analysis
  • Fig. 15 Anxiety disorders and depression treatment market: Drug type segment dashboard
  • Fig. 16 Anxiety disorders and depression treatment market: Drug type market share analysis, 2024 & 2030
  • Fig. 17 Antidepressants market, 2018 - 2030 (USD Million)
  • Fig. 18 Anxiolytics market, 2018 - 2030 (USD Million)
  • Fig. 19 Anticonvulsants market, 2018 - 2030 (USD Million)
  • Fig. 20 Noradrenergic agents market, 2018 - 2030 (USD Million)
  • Fig. 21 Atypical antipsychotics market, 2018 - 2030 (USD Million)
  • Fig. 22 Anxiety disorders and depression treatment market: Indication segment dashboard
  • Fig. 23 Anxiety disorders and depression treatment market: Indication market share analysis, 2024 & 2030
  • Fig. 24 Depression market, 2018 - 2030 (USD Million)
  • Fig. 25 Anxiety market, 2018 - 2030 (USD Million)
  • Fig. 26 Anxiety disorders and depression treatment market: Distribution channel segment dashboard
  • Fig. 27 Anxiety disorders and depression treatment market: Distribution channel market share analysis, 2024 & 2030
  • Fig. 28 Hospital pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 29 Retail pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 30 Others market, 2018 - 2030 (USD Million)
  • Fig. 31 Anxiety disorders and depression treatment market revenue, by region
  • Fig. 32 Regional marketplace: Key takeaways
  • Fig. 33 Regional marketplace: Key takeaways
  • Fig. 34 North America anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. country dynamics
  • Fig. 36 U.S. anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 37 Canada country dynamics
  • Fig. 38 Canada anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 39 Mexico country dynamics
  • Fig. 40 Mexico anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 41 Europe anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 42 UK country dynamics
  • Fig. 43 UK anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 44 Germany country dynamics
  • Fig. 45 Germany anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 46 France country dynamics
  • Fig. 47 France anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 48 Italy country dynamics
  • Fig. 49 Italy anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 50 Spain country dynamics
  • Fig. 51 Spain anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 52 Norway country dynamics
  • Fig. 53 Norway anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 54 Sweden country dynamics
  • Fig. 55 Sweden anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 56 Denmark country dynamics
  • Fig. 57 Denmark anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 58 Asia Pacific anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 59 Japan country dynamics
  • Fig. 60 Japan anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 61 China country dynamics
  • Fig. 62 China anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 63 India country dynamics
  • Fig. 64 India anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 65 Australia country dynamics
  • Fig. 66 Australia anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 67 South Korea country dynamics
  • Fig. 68 South Korea anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 69 Thailand country dynamics
  • Fig. 70 Thailand anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 71 Latin America anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 72 Brazil country dynamics
  • Fig. 73 Brazil anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 74 Argentina country dynamics
  • Fig. 75 Argentina anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 76 MEA anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 77 South Africa country dynamics
  • Fig. 78 South Africa anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 79 Saudi Arabia country dynamics
  • Fig. 80 Saudi Arabia anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 81 UAE country dynamics
  • Fig. 82 UAE anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 83 Kuwait country dynamics
  • Fig. 84 Kuwait anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 85 Company categorization
  • Fig. 86 Company market position analysis
  • Fig. 87 Strategic framework